T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$2.72B |
| 2 |
Bank of New York Mellon
BK
|
$1.14B |
| 3 |
Elevance Health
ELV
|
$979M |
| 4 |
Medtronic
MDT
|
$893M |
| 5 |
DD
Du Pont De Nemours E I
DD
|
$830M |
Top Sells
| 1 |
AGN
ALLERGAN INC
AGN
|
$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
$946M |
| 4 |
Aptiv
APTV
|
$940M |
| 5 |
Trip.com Group
TCOM
|
$644M |
Sector Composition
| 1 | Healthcare | 21.06% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.15% |
| 4 | Industrials | 11.81% |
| 5 | Technology | 9.76% |
